
Rula Hajj-Ali
@rulahajjalimd
Professor of Medicine. Vice Chair Rheumatology. Vasculitis Center, Associate Director. Cleveland Clinic. Special Needs advocate . Views and opinions are my own.
ID: 1044578454002429952
25-09-2018 13:24:45
244 Tweet
703 Followers
398 Following

Dr Peter Merkel presents data on Vilobelimab, a monoclonal Ab for C5a in AAV. Vilobelimab has the potential to 1-induce remission along with the use of RTX or CYC with no steroids 2-reduce GC toxicity #IXchange trial Vasculitis 2022Vasculitis Foundation


Thank you Dr Fussner for deep dive into Pexivas data on DAH. Plasmapheresis did not change mortality in patients with or without DAH or by severity of DAH.Lynn Fussner Vasculitis 2022

So happy to connect with old Irish friend who is highly missed in Cleveland #Dublin Leonard Calabrese


The incredible Peter Merkel holds court at Penn w the VCRC at #ACR22 - amazing job at organizing as always Rula Hajj-Ali Peter Grayson KenWarringtonMD Vasculitis Foundation #vasculitis Cassandra Calabrese


Rula Rula Hajj-Ali presents the VCRC plan that will revolutionize and transform the field of CNS vasculitis!! #ACR22. Methodically One patient at a time!!! Cassandra Calabrese Mike Putman Anisha Dua Peter Grayson KenWarringtonMD


This work will not not be successful without the support of Len Calabrese Leonard Calabrese. Thank you Len for all your work and support in this domain 🙏

Happening now. Carol Langford giving the year in Review# ACR2022 Cassandra Calabrese Emily Littlejohn Adam J BrownLeonard Calabrese


Vilobelimab , C5 a inhibitor , in phase 2 trial induced remission together with RTX or CYC with substantial reduction in the dose and toxicity of GC. One arm with no GC!! Vasculitis Foundation Kevin Byram, MD KenWarringtonMD Anisha Dua


These two powerhouses in one frame! Lisa Zickuhr Rula Hajj-Ali. The warm hugs after a virtual madness adds so much ❤️


Check out our data by Dr Vural Adil F Vural, MD comparing efficacy and safety when switching from RTX to RTX-pvvr in maintenance therapy in GPA. 98% of pts remained in rem with = infect and infusion rx,PROMIS Vasculitis Foundation Mike Putman KenWarringtonMD


Honored to receive the international innovations award 2022 from the #vattikutifoundation Humbled by the hi quality work presented by colleagues across surgical specialties. Mahendra bhandari Vattikuti Foundation Dr. J. Kaouk Cleveland Clinic MD Cleveland Clinic Urology

Excited to announce my match at Indiana University for Internal Medicine Residency #Match2023! Very thankful for the opportunity and forever grateful for the support of my family, friends and mentors Indiana University Internal Medicine Inside The Match The Internal Med Applicant ☤ IMG_stories Advocates for IMGs



So exciting time for Vasculitis!!Multiple current and planned clinical trials in different types of vasculitides presented at Vasculitis Research Investigators meeting Vasculitis Foundation #ACR23 Cleveland Clinic MD KenWarringtonMD Kevin Byram, MD Adam J Brown


Check out our poster on the largest cohort of Susac s/o to date!! presented by The Adam Brown. Rituximab has a role in this disease Adam J Brown #ACR23 Cleveland Clinic MDEmily Littlejohn


Check out our poster on non infectious uveitis by Dr Koenig. Posterior and intermediate uveitis location is associated with longest duration of therapy. The earlier Rx with IS the shorter the duration of treatment.#ACR23Cleveland Clinic MDTaylor Koenig


Great work by Dr Littlejohn. Longitudinal ANA titers decreased overtime . Need further evaluation whether correlate with disease activity Emily Littlejohn Cleveland Clinic MD #ACR23 Lupus Foundation of America


Check out the work by Dr Vondenberg in SLE. NPSLE is associated with more hospitalization and immunosuppressive therapy James Vondenberg Cleveland Clinic MD #ACR23 Lupus Foundation of America


Pregnancies with vasculitis had a higher risk of preterm delivery and preeclampsia/eclampsia.SVV are at higher risk. Claim data presented at Plenary session Vasculitis Foundation #ACR23 KenWarringtonMD

Neurologic involvement is often reported in individuals with ANCA-associated vasculitis & can be associated with disability & chronic pain, according to findings from a retrospective analysis presented by Rula Hajj-Ali at #ACR23. Read more ➡️ brnw.ch/21wEzcX American College of Rheumatology